MarketsandMarkets

ImmunoBio Series 2024 - UK Edition

07th - 8th March 2024

Park Plaza Victoria London by Radisson, 239 Vauxhall Bridge Rd, Pimlico, London SW1V 1EQ, UK

Avail Your Ticket Avail
Your Ticket
Become A Sponsor Become
A Sponsor
Become A Speaker Become
A Speaker

EVENT OVERVIEW

Bridging Science, Innovation, and Health for a Better Tomorrow

MarketsandMarkets presents the Immunobio Series, an extraordinary set of conferences taking place on 7-8 March 2024 in London, UK.

MarketsandMarkets 5th Annual Biomarker and Companion Diagnostics Conference:

Dive into the world of biomarkers at our flagship event, uniting experts and industry leaders to drive innovation in healthcare, diagnostics, and personalized medicine. Explore groundbreaking research and applications, fostering collaboration and knowledge sharing. This conference will convene experts, researchers, scientists, academicians, and industry leaders from across the USA to drive innovation and collaboration. Esteemed keynote speakers will provide groundbreaking insights into the latest developments and future prospects of biomarker research. This annual event is served as a hub for knowledge sharing, collaboration, and exploration of the latest developments in biomarker research and applications.

MarketsandMarkets 8th Annual Next Gen Immuno-Oncology Conference:

Explore the forefront of cancer treatment at our flagship Immuno-Oncology Conference. Keynote presentations, Brainstorming Panel Discussions and Case studies will give the stakeholders an opportunity to discuss and understand the issues faced and come up with solutions. With more than 40 speakers across the world from pharma, biopharma and biotech companies, the congress will discuss the latest updates and share insights in development of ADC’s, Monoclonal Antibodies, Bispecific Antibodies, Immune Checkpoint Inhibitors and Cellular Therapy shaping the future of immuno-oncology.

Join us for this transformative event, where innovation meets collaboration, shaping the future of healthcare and biotechnology.

CO-LOCATED CONFERENCES

8th Annual MarketsandMarkets Next-Gen Immuno-Oncology Conference
5th Annual MarketsandMarkets Biomarker and Companion Diagnostics Conference

WHAT TO EXPECT

  1. Cutting-Edge Insights: Access the latest advancements in biomarker discovery, precision medicine, and clinical applications spanning cancer, immunology, neurodegenerative disorders, and cardiovascular biomarkers.
  2. Innovative Immunotherapy: Dive into immune-oncology projects, exploring antibodies, cellular therapy, and immune checkpoint research. Contribute to interactive discussions, share your work, and stay updated on cutting-edge technologies and platforms.
  3. Networking and Collaboration: Connect with industry leaders, researchers, and peers. Foster collaborations, engage in thought-provoking discussions, and explore partnership opportunities.
  4. Professional Development: Enhance your skills with workshops on biomarker data analysis, machine learning, and artificial intelligence applications. Learn best practices and methodologies for biomarker and IO research.
  5. Practical Applications: Discover how research translates into real-world applications. Explore exhibitor showcases, demonstrations, and case studies, gaining insights into the latest tools and technologies.
  6. Personal and Industry Growth: Step out of your comfort zone, engage in interactive roundtables, and contribute to key discussions. Elevate your personal and professional growth within the dynamic fields of biomarker research and immunotherapy.

Immerse yourself in groundbreaking research, expand your network, and drive innovation at the Immunobio Series, where science meets collaboration.

Steam A - Biomarker and Companion Diagnostics Conference

Stream B & C- Next Gen Immuno-Oncology Conference
  1. Biomarker Discovery: Discussions on novel techniques and strategies for identifying new biomarkers, including genomics, proteomics, metabolomics, and bioinformatics.
  2. Precision Medicine: The role of biomarkers in tailoring treatments to individual patients for better efficacy and reduced side effects.
  3. Clinical Validation and Validation Strategies: Strategies for rigorously validating biomarkers for clinical use and addressing challenges in biomarker validation.
  4. Clinical Applications of Biomarker: Cancer, Immunology, Neurodegenerative Disorders, Cardiovascular Biomarkers
  5. Bioinformatics and Data Analysis: Workshops and sessions on the analysis of biomarker data, including machine learning and artificial intelligence approaches.
  6. Biomarker-Based Diagnostics: Presentations on the development and commercialization of biomarker-based diagnostic tests and platforms.
  7. Collaborations and Industry Partnerships: Sessions on fostering collaboration between academia, industry, and government agencies to advance biomarker research.

 
  1. Preclinical and Translational Immuno-Oncology Developments
  2. Next Gen Antibodies and Targeted Therapies
  3. Immune Checkpoint Inhibitors and Combination Therapies
  4. Tumor Microenvironment and Cancer Biomarkers
  5. CAR-T cell therapy, T Cell Therapy, Adoptive Cell Therapy
  6. Cancer Vaccines and Cancer Microbiome
  7. Personalizing Cancer Treatment- Challenges and Opportunities

 

Expression #1 of SELECT list is not in GROUP BY clause and contains nonaggregated column 'cnceventswithcrm.s.id' which is not functionally dependent on columns in GROUP BY clause; this is incompatible with sql_mode=only_full_group_by